The TB structural genomics consortium: A resource for Mycobacterium tuberculosis biology

Tuberculosis

Volumn 83, Issue 4, 2003, Pages 223-249

  Terwilliger, T C ^a   Park, M S ^a   Waldo, G S ^a   Berendzen, J ^a   Hung, L W ^a   Kim, C Y ^a   Smith, C V ^b   Sacchettini, J C ^b   Bellinzoni, M ^c   Bossi, R ^c   De Rossi, E ^c   Mattevi, A ^c   Milano, A ^c   Riccardi, G ^c   Rizzi, M ^c   Roberts, M M ^d   Coker, A R ^e   Fossati, G ^f   Mascagni, P ^f   Coates, A R M ^d   Wood, S P ^e   Goulding, C W ^g   Apostol, M I ^g   Anderson, D H ^g   Gill, H S ^g   Eisenberg, D S ^g   Taneja, B ^h   Mande, S ^h   Pohl, E ⁱ   Lamzin, V ⁱ   Tucker, P ⁱ   Wilmanns, M ⁱ   Colovos, C ⁱ   Meyer Klaucke, W ⁱ   Munro, A W ^j   McLean, K J ^j   Marshall, K R ^j   Leys, D ^j   Yang, J K ^k   Yoon, H J ^k   Lee, B I ^k   Lee, M G ^k   Kwak, J E ^k   Han, B W ^k   Lee, J Y ^k   Baek, S H ^k   Suh, S W ^k   Komen, M M ^l   Arcus, V L ^l   Baker, E N ^l   Lott, J S ^l   Jacobs Jr , W ^m   Alber, T ⁿ   Rupp, B ^o   more..

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f Italfarmaco SpA   (Italy)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

ⁱ DESY   (Germany)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

^k Seoul National University   (South Korea)

^l UNIVERSITY OF AUCKLAND   (New Zealand)

^m ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

more..

Author keywords

Drug discovery; Mycobacterium tuberculosis; Protein structure; Structural genomics; X ray crystallography

Indexed keywords

GENE STRUCTURE; GENOMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TUBERCULOSIS;

EID: 10744233879     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(03)00051-9     Document Type: Review

References (134)

1. Burley SK. An overview of structural genomics. Nat Struct Biol 2000;7:932-4.
2. Brenner SE, Levitt M. Expectations from structural genomics. Protein Sci 2000;9:197-200.
3. Terwilliger TC, Waldo G, Peat TS, Newman JM, Chu K, Berendzen J. A protein structure initiative. Protein Sci 1998;7:1851-6.
4. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs Jr WR, Russell DG. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000;406:735-8.
5. Honer Zu Bentrup K, Miczak A, Swenson DL, Russell DG. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J Bacteriol 1999;181:7161-7.
6. Graham JE, Clark-Curtiss JE. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophases by selective capture of transcribed sequences SCOTS. Proc Natl Acad Sci USA 1999;96:11554-9.
7. Sharma V, Sharma S, Hoener zu Bentrup K, McKinney JD, Russell DG, Jacobs Jr WR, Sacchettini JC. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol 2000;7:663-8.
8. Huang C, Sacchettini J., in preparation, 2002.
9. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
10. Diehl P, McFadden BA. Site-directed mutagenesis of lysine 193 in Escherichia coli isocitrate lyase by use of unique restriction enzyme site elimination. J Bacteriol 1993;175:2263-70.
11. Rehmann A, McFadden BA. Cysteine 195 has a critical functional role in catalysis by isocitrate lyase from Escherichia coli. Curr Microbiol 1997;35:267-369.
12. Rehman A, McFadden BA. Lysine 194 is functional in isocitrate lyase from Escherichia coli. Curr Microbiol 1997;35:14-7.
13. Rehman A, McFadden BA. Serine 319 and 321 are functional in isocitrate lyase from Escherichia coli. Curr Microbiol 1997;34:205-11.
14. Luttik MA, Kotter P, Salomons FA, van der Klei IJ, van Dijken JP, Pronk JT. The Saccharomyces cerevisiae ICL2 gene encodes a mitochondrial 2-methylisocitrate lyase involved in propionyl-coenzyme A metabolism. J Bacteriol 2000;182:7007-13.
15. Brock M, Darley D, Textor S, Buckel W. 2-Methylisocitrate lyases from the bacterium Escherichia coli and the filamentous fungus Aspergillus nidulans: characterization and comparison of both enzymes. Eur J Biochem 2001;268:3577-86.
16. Horswill AR, Escalante-Semerena JC. Propionate catabolism in Salmonella typhimurium LT2: two divergently transcribed units comprise the prp locus at 8. 5 centisomes, prpr encodes a member of the sigma-54 family of activators, and the prpbcde genes constitute an operon. J Bacteriol 1997;179:928-40.
17. Cole ST, Eiglmeier K, Parkhill J, et al. Massive gene decay in the leprosy bacillus. Nature 2001;409:1007-111.
18. Britton K, Langridge S, Baker PJ, Weeradechapon K, Sedelnikova SE, De Lucas JR, Rice DW, Turner G. The crystal structure and active site location of isocitrate lyase from the fungus Aspergillus nidulans. Struct Fold Des 2000;8:349-62.
19. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80.
20. + biosynthesis. Adv Enzymol Relat Areas Mol Biol 1999;73:135-82.
21. Rizzi M, Nessi C, Mattevi A, Coda A, Bolognesi M, Galizzi A. Crystal structure of NH3 dependent NAD synthetase from Bacillus subtilis. EMBO J 1996;15:5125-33.
22. + synthetase. J Bacteriol 1998;180:3218-21.
23. + synthetase. Protein Expres Purif 2002;25(3):547-57.
24. + revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase. Biochemistry 2002;41(28):8807-18.
25. Litwin CM, Calderwood SB. Role of iron in regulation of virulence genes. Clin Microbiol Rev 1993;16:137-49.
26. Zahrt TC, Song J, Siple J, Deretic V. Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG. Mol Microbiol 2001;39:1174-85.
27. Milano A, Forti F, Sala C, Riccardi G, Ghisotti D. Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis. J Bacteriol 2001;183:6801-6.
28. Rye HS, Roseman AM, Chen S, Furtak K, Fenton WA, Saibil HR, Horwich AL. GroEL-GroES cycling: ATP and nonnative polypeptide direct atternation of folding-active rings. Cell 1999;97:325-38.
29. Kong TH, Coates ARM, Butcher PD, Hickman CJ, Shinnick TM. Mycobacterium tuberculosis expresses two cpn60 homologs. Proc Natl Acad Sci USA 1993;90:2608-12.
30. Roberts MM, Coker AR, Fossati G, Mascagni P, Coates ARM, Wood SP. Crystallization, X-ray diffraction and preliminary structure analysis of Mycobacterium tuberculosis chaperonin 10. Acta Crystallogr D 1999;55:910-4.
31. Taneja B, Mande SC. Three-dimensional structure of Mycobacterium tuberculosis chaperonin-10 reveals a partially stable conformation of its mobile loop. Curr Sci 2001;81:87-91.
32. Taneja B, Mande SC. Structure of Mycobacterium tuberculosis chaperonin 10 at 3.5Å resolution. Acta Crystallogr D 2002;58:260-6.
33. Adams PD, Pannu NS, Read RJ, Brünger AT. Cross-validated maximum likelihood enhances simutated annealing refinement. Proc Natl Acad Sci USA 1997;94:5018-23.
34. Rice LM, Brünger AT. Torsion angle dynamics: reduced variable conformational sampling enhances crystallographic structure refinement. Proteins: Struct Funct Genet 1994;19:277-90.
35. Brünger AT. Crystallographic refinement by simulated anneating. Application to a 2.8Å resolution structure of aspartate aminotransferase. J Mol Biol 1988;203:803-16.
36. Brünger AT, Adams PD, Clore GM, et al. Crystallography & NMR system (CNS): a new software suite for macromolecular structure determination. Acta Crystallogr D 1998;54:905-21.
37. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714-23.
38. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 1994;50:760-763.
39. Kleywegt GJ, Jones TA. xdlMAPMAN and xdlDATAMAN, programs for reformatting, analysis and manipulation of biomacromolecular electron-density maps and reflection data sets. Acta Crystallogr D 1996;52:826-8.
40. Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971;55:379-400.
41. Hunt JF, Weaver AJ, Landry SJ, Gierasch L, Deisenhofer J. The crystal structure of the GroES co-chaperonin at 2.8Å resolution. Nature 1996;379:37-45.
42. Mande SC, Mehra V, Bloom BR, Hol WG. Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science 1996;271:203-7.
43. Hunt JF, van der Vies SM, Henry L, Deisenhofer J. Structural adaptations in the specialized bacteriophage T4 co-chaperonin Gp31 expand the size of the Anfinsen cage. Cell 1997;90:361-71.
44. Landry SJ, Zeilstra-Ryalls J, Fayet O, Georgopoulos C, Gierasch LM. Characterization of a functionally important mobile domain of GroES. Nature 1993;364:255-8.
45. Xu Z, Horwich AL, Sigler PB. The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature 1997;388:741-9.
46. Landry SJ, Taher A, Georgopoulos C, van der Vies SM. Interplay of structure and disorder in cochaperonin mobile loops. Cell 1996;90:361-71.
47. Landry SJ, Steede NK, Maskos K. Temperature dependence of backbone dynamics in loops of human mitochondrial heat shock protein 10. Biochemistry 1997;36:10975-86.
48. Laskowski RA, McArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the quality of protein structures. J Appl Crystallogr 1993;26:283-91.
49. Vaguine AA, Richelle J, Wodak SJ. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. Acta Crystallogr D 1999;55:191-205.
50. Luzzatti PV. Traitement statistique des erreurs dans la determination des structures cristallines. Acta Crystallogr 1952;5:802-10.
51. Matthews BW. Solvent content of protein crystals. J Mol Biol 1968;33:491-7.
52. World Health Organization. The World Health report 1998: life in the 21st century - a vision for all. Geneva, Switzerland: The World Health Organization; 1998.
53. Guilhot C, Jackson M, Gicquel B, Mycobacteria: molecular biology and virulence. Blackwell Science Ltd, Oxford; 1999: p. 17-37.
54. http://www.doe-mbi.ucla.edu/TB/
55. Goulding CW, Perry LJ, Anderson DH et al. Progress at UCLA structural genomics of Mycobacterium tuberculosis: A preliminary report of progress at UCLA, Biophysical Chem 2003: in press.
56. Harth G, Horwitz MA. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 1999;189:1425-36.
57. Tullius MV, Harth G, Horwitz MA. High extracellular levels of Mycobacterium tuberculosis glutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infect Immun 2001;69:6348-63.
58. Harth G, Clemens DL, Horwitz MA. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA 1994;91:9342-6.
59. Hirschfield GR, McNeil M, Brennan PJ. Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol 1990;172:1005-13.
60. Gill HS, Pfluegl GM, Eisenberg D. Preliminary crystallographic studies on glutamine synthetase from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr 1999;55:865-8.
61. Gill HS, Pfluegl GMU, Eisenberg D. Multicopy crystallographic refinement of a relaxed glutamine synthetase from Mycobacterium tuberculosis highlights flexible loops in enzymatic mechanism. Biochemistry 2002;41(31):9863-72.
62. Gill HS, Eisenberg D. The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry 2001;40:1903-12.
63. Naito M, Ohara N, Matsumoto S, Yamada T. The novel fibronectin-binding motif and key residues of mycobacteria. J Biol Chem 1998;273:2905-9.
64. Nardini M, Ridder IS, Rozeboom HJ, et al. The X-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1. An enzyme to detoxify harmful epoxides. J Biol Chem 1999;274:14579-86.
65. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997;276:1420-2.
66. Horwitz MA, Lee BW, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995;92:1530-4.
67. Ronning DR, Klabunde T, Besra GS, Vissa VD, Belisle JT, Sacchettini JC. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nature Struct Biol 2000;7:141-6.
68. Anderson DH, Harth G, Horwitz MA, Eisenberg D. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol 2001;307:671-81.
69. Naito M, Fukuda T, Sekiguchi K, Yamada T. The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection. Biochem J 2000;347:725-31.
70. Debarbieux L, Beckwith J. Electron avenue: pathways of disulfide bond formation and isomerization. Cell 1999;99:117-9.
71. Wiker HG, Michell SL, Hewinson RG, Spierings E, Nagai S, Harboe M. Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis. Microbial Pathog 1999;26:207-19.
72. Gomez M, Johnson S, Gennaro ML. Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect Immun 2000;68:2323-7.
73. Li Q, Hu H, Xu G. Biochemical characterization of the thioredoxin domain of Escherichia coli DsbE protein reveals a weak reductant. Biochem Biophys Res Commun 2001;283:849-53.
74. Martin JL. Thioredoxin - a fold for all reasons. Structure 1995;3:245-50.
75. Goulding CW, Apostol MI, Parseghian A, Gennaro M, Eisenberg D. 1. 1Å resolution crystal structure of a secreted Mycobacterium tuberculosis disulfide oxidoreductase homologous to E. coli DsbE: implications for function, 2003, in preparation.
76. Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nature Struct Biol 1997;4:490-7.
77. Hennig M, D'Arcy A, Hampele IC, Page MG, Oefner C, Dale GE. Crystal structure and reaction mechanism of 7,8-dihydroneopterin aldolase from Staphylococcus aureus. Nature Struct Biol 1998;5:357-62.
78. Ploom T, Haussmann C, Hof P, et al. Crystal structure of 7,8-dihydroneopterin triphosphate epimerase. Struct Fold Des 1999;7:509-16.
79. Goulding CW, Apostol MI, Parseghian A, Sawaya M, Eisenberg D. Crystal structure of FolB - implications for drug design, 2003, in preparation.
80. Manca C, Lyashchenko K, Wiker HG, Usai D, Colangeli R, Gennaro ML. Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun 1997;65:16-23.
81. Lee BY, Horwitz MA. T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infect Immun 1999;67:2665-70.
82. Braunstein M, Griffin TI, Kriakov JI, Friedman ST, Grindley ND, Jacobs Jr WR. Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn552′phoA in vitro transposition system. J Bacteriol 2002;182:2732-40.
83. Goulding CW, Parseghian A, Sawaya MR, Cascio D, Apostol MI, Gennaro ML, Eisenberg D. Crystal structure of a major secreted protein of Mycobacterium tuberculosis - MPT63 at 1.5-A resolution. Protein Sci 2002;11(12):2887-93.
84. Halaby DM, Mornon JP. The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity. J Mol Evol 1998;46:389-400.
85. Hirsch JA, Schubert C, Gurevich W, Sigler PB. The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell 1999;97:257-69.
86. Owen DJ, Vallis Y, Pearse BM, McMahon HT, Evans PR. The structure and function of the beta 2-adaptin appendage domain. EMBO J 2000;19:4216-27.
87. Hamburger ZA, Brown MS, Isberg RR, Bjorkman PJ. Crystal structure of invasin: a bacterial integrin-binding protein. Science 1999;286:291-5.
88. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996;381:571-80.
89. Sternberg N. Properties of a mutant of Escherichia coli defective in bacteriophage head formation (groE). I. Initial characterization. J Mol Biol 1973;76:1-23.
90. Hemmingsen SM, Woolford C, van der Vies SM, et al. Homologous plant and bacterial proteins chaperone oligomeric protein assembly. Nature 1988;333:330-4.
91. Xu Z, Horwich AL, Sigler PB. The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature 1997;388:741-50.
92. Hunt JF, Weaver AJ, Landry SJ, Gierasch L, Deisenhofer J. The crystal structure of GroES co-chaperonin at 2.8Å resolution. Nature 1996;379:37-45.
93. Murzin AG. Structural classification of proteins: new superfamilies. Curr Opin Struct Biol 1996;6:386-94.
94. Taneja B, Mande SC. Conserved structural features and sequence patterns in the GroES fold family. Protein Eng 1999;12:815-8.
95. Taneja B, Mande SC. Metal ions modulate the plastic nature of Mycobacterium tuberculosis chaperonin-10. Protein Eng 2001;14:391-5.
96. Timchenko AA, Melnik BS, Kihara H, Kimura K, Semisotnov GV. GroES co-chaperonin small angle X-ray scattering study shows ring orifice increase in solution. FEBS Lett 2000;471:211-4.
97. Young DB, Garbe TR. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun 1991;59:3086-93.
98. Mehra V, Bloom BR, Bajardi AC, et al. A major T-cell antigen of Mycobacterium leprae is a 10-kD heat shock cognate protein. J Exp Med 1992;175:275-84.
99. Cobb AJ, Frothingham R. The GroES antigens of Mycobacterium avium and Mycobacterium paratuberculosis. Vet Microbiol 1999;67:31-5.
100. Kim J, Sette A, Rodda S, et al. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J Immunol 1997;159:335-43.
101. Chua-Intra B, Peerapakorn S, Davey N, et al. T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts. Infect Immun 1998;66:4903-9.
102. Meghji S, White PA, Nair SP, et al. Mycobacterium tuberculosis chaperonin-10 stimulates bone resorption: a potential contributory factor in pott's disease. J Exp Med 1997;186:1241-6.
103. Abou-Zeid C, Smith I, Grange JM, Ratliff TL, Steele J, Rook GA. The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol 1988;134:531-8.
104. 2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J Exp Med 2000;191:287-302.
105. Pohl E, González A, Hermes C, van Silfhout RG. Overview of the tunable beamlines for protein crystallography at the EMBL Hamburg outstation; an analysis of current, future usage and developments. J Synchr Rad 2001;8:1113-20.
106. Pohl E, Holmes RK, Hol WGJ. Crystal structure of the iron-dependent regulator (IdeR) from Mycobacterium tuberculosis shows both metal binding sites fully occupied. Mol Biol 1999;286:1145-56.
107. Pym AS, Domenech P, Honore N, Song J, Deretic V, Cole ST. Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol Microbiol 2001;40:879-89.
108. Goulding, C, 2002, unpublished results.
109. Grandoni JA, Marta PT, Schloss VT. Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents. J Antimicrob Chemother 1998;42:475-82.
110. Lang D, Thoma R, Henn-Sax M, Sterner R, Wilmanns M. Structural evidence for evolution of the beta/alpha barrel scaffold by gene duplication and fusion. Science 2000;289:1546-50.
111. Morth JP, Tucker P, unpublished results.
112. Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J, Halada P, Lamer S, Hagens K, Kaufmann SHE. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999;33:1103-17.
113. Mollenkopf H-J, Jungblut PR, Raupach B, Mattow J, Lamer S, Zimny-Arndt U, Schaible UE, Kaufmann SHE. A dynamic 2D-PAGE database: the mycobacterial proteome via internet. Electrophoresis 1999;20:2172-80.
114. Porter TD, Coon MJ. Cytochrome P450: multiplicity of isoforms, substrates and catalytic and regulatory mechanisms. J Biol Chem 1991;266:13469-72.
115. Kunst F, Ogasawara N, Moszer I, et al. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis. Nature 1997;390:249-56.
116. Munro AW, Lindsay JG. Bacterial cytochromes P450. Mol Microbiol 1996;20:1115-25.
117. Nelson DR, Koymans L, Kamataki, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996;6:1-42.
118. Bellamine A, Mangla AT, Nes WD, Waterman MR. Characterization and catalytic properties of the sterol 14α-demethylase from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1999;96:8937-42.
119. Podust LM, Poutos TL, Waterman MR. Crystal structure of cytochrome P450 14 alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA 2001;98:3068-73.
120. Souter A, McLean KJ, Smith WE, Munro AW. The genome sequence of Mycobacterium tuberculosis reveals cytochromes P450 as novel anti-TB drug targets. J Chem Technol Biotechnol 2000;75:933-41.
121. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein folding assay using green fluorescent protein. Nature Biotechnol 1998;17:691-5.
122. Yang JK, Yoon H-J, Ahn HJ, Lee BI, Cho SH, Waldo GS, Park MS, Suh SW. Crystallization and preliminary X-ray crystallographic analysis of the Rv2002 gene product from Mycobacterium tuberculosis, a beta-ketoacyl carrier protein reductase homologue. Acta Crystallogr 2002;D58:303-5.
123. Scorpio A, Zhang Y. Mutations in pncA, agene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Med 1996;2:662-7.
124. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerging Infectious Dis 1998;4:195-209.
125. Wilson M, DeRisi J, Kristensen HH, et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 1999;96:12833-8.
126. Hube B, Stehr F, Bossenz M, et al. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol 2000;174:362-74.
127. Cole ST. Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Lett 1999;452:7-10.
128. Kouker G, Jaeger K-E. Specific and sensitive plate assay for bacterial lipases. Environ Microbiol 1987;53:211-3.
129. van Kampen MD, Rosenstein R, Gotz F, Egmond MR. Cloning, purification and characterisation of Staphylococcus warneri lipase 2. Biochim Biophys Acta 2001;1544:229-41.
130. Langfort J, Ploug T, Ihlemann J, et al. Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle. Biochem J 1999;340:459-65.
131. Mdluli K, Sherman DR, Hickey MJ, et al. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infectious Dis 1996;174:1085-90.
132. Sherman DR, Voskuil M, Schnappinger D, et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci USA 2001;98:7534-9.
133. Alland D, Kramnik I, Weisbrod TR, et al. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998;95:13227-32.
134. Alland D, Steyn AJ, Weisbrod T, Aldrich K, Jacobs Jr WR. Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition. J Bacteriol 2000;182:1802-11.